Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

AstraZeneca
Queensland Health
Covington
Johnson and Johnson
UBS
Argus Health
Moodys
Baxter
Citi

Generated: October 15, 2018

DrugPatentWatch Database Preview

Suppliers and packages for generic ingredient: ENOXAPARIN SODIUM

« Back to Dashboard

ENOXAPARIN SODIUM

Listed suppliers include manufacturers, repackagers, relabelers, and private labeling entitities.

Applicant Tradename Generic Name Dosage NDA NDA/ANDA Supplier Package Code Package
Sanofi Aventis Us LOVENOX enoxaparin sodium INJECTABLE;INTRAVENOUS, SUBCUTANEOUS 020164 NDA sanofi-aventis U.S. LLC 0075-0620-40 10 SYRINGE in 1 CARTON (0075-0620-40) > .4 mL in 1 SYRINGE
Sanofi Aventis Us LOVENOX enoxaparin sodium INJECTABLE;INTRAVENOUS, SUBCUTANEOUS 020164 NDA sanofi-aventis U.S. LLC 0075-0621-60 10 SYRINGE in 1 CARTON (0075-0621-60) > .6 mL in 1 SYRINGE
Sanofi Aventis Us LOVENOX enoxaparin sodium INJECTABLE;INTRAVENOUS, SUBCUTANEOUS 020164 NDA sanofi-aventis U.S. LLC 0075-0622-80 10 SYRINGE in 1 CARTON (0075-0622-80) > .8 mL in 1 SYRINGE
Sanofi Aventis Us LOVENOX enoxaparin sodium INJECTABLE;INTRAVENOUS, SUBCUTANEOUS 020164 NDA sanofi-aventis U.S. LLC 0075-0623-00 10 SYRINGE in 1 CARTON (0075-0623-00) > 1 mL in 1 SYRINGE
Sanofi Aventis Us LOVENOX enoxaparin sodium INJECTABLE;INTRAVENOUS, SUBCUTANEOUS 020164 NDA sanofi-aventis U.S. LLC 0075-0624-30 10 SYRINGE in 1 CARTON (0075-0624-30) > .3 mL in 1 SYRINGE
Sanofi Aventis Us LOVENOX enoxaparin sodium INJECTABLE;INTRAVENOUS, SUBCUTANEOUS 020164 NDA sanofi-aventis U.S. LLC 0075-0626-03 1 VIAL, MULTI-DOSE in 1 CARTON (0075-0626-03) > 3 mL in 1 VIAL, MULTI-DOSE
Applicant Tradename Generic Name Dosage NDA NDA/ANDA Supplier Package Code Package

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

US Department of Justice
Teva
Johnson and Johnson
AstraZeneca
Baxter
McKinsey
Federal Trade Commission
Accenture
Deloitte